Infectious complications associated with ventricular assist systems

ASAIO Journal

Volumn 46, Issue 6, 2000, Pages

  Myers, Timothy J ^a   Khan, Tehreen ^a   Frazier, O H ^a,b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; ARTIFICIAL ORGANS; BIOTECHNOLOGY; CARDIOVASCULAR SURGERY; CARDIOVASCULAR SYSTEM; IMPLANTS (SURGICAL); TRANSPLANTATION (SURGICAL);

HEART TRANSPLANTATION; INFECTION; VENTRICULAR ASSIST SYSTEMS;

CARDIOLOGY;

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; BLOOD PUMP; ENDOTRACHEAL TUBE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INDWELLING CATHETER; INFECTION CONTROL; INFECTION RATE; INFECTION SENSITIVITY; INTRAVASCULAR CATHETER; MORTALITY; POSTOPERATIVE HEMORRHAGE; REVIEW; THROMBOSIS;

EID: 0034326870     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200011000-00034     Document Type: Review

References (65)

1. Mechanical circulatory support as a bridge to transplantation: Past, present and future
2. Will permanent LVASs be better than heart transplantation?
3. Infections during extended circulatory support: University of Alabama at Birmingham Experience 1989 to 1994
4. Infection during circulatory support with ventricular assist devices
5. Implantable LVAS infections: Implications for permanent use of the device
6. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system
7. Infectious complications in left ventricular assist device recipients
8. Results of extended bridge to transplantation: Window into the future of permanent ventricular assist devices
9. Clinical experience with 111 Thoratec ventricular assist devices
10. Eleven years' experience with the Pierce-Donachy ventricular assist device
11. Mechanical circulatory support: The Bad Oeynhausen experience
12. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation
13. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices
14. Acute and temporary ventricular support with Biomedicus centrifugal pump
15. ABIOMED BVS 5000: Experience and potential advantages
16. Combined Registry for the Clinical Use of Mechanical Ventricular Assist Pumps and the Total Artificial Heart in conjunction with heart transplantation: Sixth official report - 1994
17. The Concerted Action 'Heart' European Registry on clinical application of mechanical circulatory support systems: Bridge to transplant. The Registry Scientific Committee
18. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application
19. Initial clinical experience with a wearable controller for the Novacor left ventricular assist system
20. Recovery of major organ function in patients awaiting heart transplantation with thoratec ventricular assist devices
21. Ventricular assist devices and total artificial hearts: A combined registry experience
22. Frequency and significance of infections in patients receiving prolonged LVAS support
23. Management of left ventricular assist device infection with heart transplantation
24. Mediastinitis complicating successful mechanical bridge to heart transplantation
25. Retrospective analysis of infection in patients undergoing support with left ventricular assist systems
26. Infections associated with implanted blood pumps
27. Immunosuppression after major surgery in normal patients
28. Analysis of risk factors for surgical wound infections following vascular surgery
29. Complement activation during cardiopulmonary bypass: Evidence for generation of C 3a and C5a anaphylatoxins
30. The effect of cardiopulmonary bypass on immune mechanisms of man
31. Activation-induced T-cell death and immune dysfunction of left ventricular assist device
32. Ventricular assist devices for postcardiotomy cardiogenic shock
33. Immune consequences of blood transfusion in the surgical patient
34. Pathogenesis, prevention and management of infections due to intravascular devices used for infusion therapy
35. Infectious complications in four long-term recipients of the Jarvik 7 artificial heart
36. A comparison between intraperitoneal and extraperitoneal left ventricular assist system placement
37. Preperitoneal placement of ventricular assist devices: An illustrated stepwise approach
38. Preperitoneal insertion of the HeartMate 1000IP Implantable Left Ventricular Assist Device
39. Human intraperitoneal response to a left ventricular assist device with a Ti-6A1- 4V alloy surface
40. Implantation technique for the Heartmate left ventricular assist device
41. The HeartMate left ventricular assist system: Overview and 12-year experience
42. Microbially infected thrombus in animals with total artificial hearts
43. Infections and thromboembolism with implantable cardiovascular devices
44. Bacterial biofilms: A common cause of persistent infections
45. Biofilms on indwelling vascular catheters
46. Prevention and control of bacterial infections associated with medical devices
47. The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals
48. The changing face of candidemia: Emergence of non-candida albicans species and antifungal resistance
49. Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis and treatment
50. Fungal sepsis in surgical patients
51. The changing face of candidemia: Emergence of non-candida albicans species and antifungal resistance
52. Management of chronic left ventricular assist device percutaneous lead insertion sites
53. Decreased bacterial adherence and biofilm formation on chlorhexadine and silver sulfadiazine-impregnated central venous catheters in swine
54. Development of an infection-resistant LVAS driveline: A novel approach to the prevention of device-related infections
55. Treatment of infected left ventricular assist device using antibiotic-impregnated beads
56. Risk stratification in patients bridged to cardiac transplantation
57. Selection scale predicts patients successfully receiving long-term, implantable left ventricular assist devices
58. Rotary pumps: New developments and future perspectives
59. In vivo evaluation of an intraventricular electric axial flow pump for left ventricular assistance